1. Home
  2. NAUT vs MASS Comparison

NAUT vs MASS Comparison

Compare NAUT & MASS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nautilus Biotechnolgy Inc.

NAUT

Nautilus Biotechnolgy Inc.

N/A

Current Price

$2.30

Market Cap

383.5M

Sector

Industrials

ML Signal

N/A

Logo 908 Devices Inc.

MASS

908 Devices Inc.

N/A

Current Price

$8.59

Market Cap

312.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NAUT
MASS
Founded
2016
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Medical/Dental Instruments
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
383.5M
312.7M
IPO Year
2020
2020

Fundamental Metrics

Financial Performance
Metric
NAUT
MASS
Price
$2.30
$8.59
Analyst Decision
Strong Buy
Buy
Analyst Count
1
1
Target Price
$4.00
$12.00
AVG Volume (30 Days)
408.3K
239.2K
Earning Date
04-28-2026
05-12-2026
Dividend Yield
N/A
N/A
EPS Growth
16.07
125.47
EPS
N/A
N/A
Revenue
N/A
$56,197,000.00
Revenue This Year
N/A
$19.44
Revenue Next Year
$992.86
$18.63
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.62
$5.03
52 Week High
$4.31
$9.34

Technical Indicators

Market Signals
Indicator
NAUT
MASS
Relative Strength Index (RSI) 38.26 59.05
Support Level $2.22 $7.56
Resistance Level $2.30 $9.20
Average True Range (ATR) 0.17 0.49
MACD -0.03 -0.03
Stochastic Oscillator 6.57 64.46

Price Performance

Historical Comparison
NAUT
MASS

About NAUT Nautilus Biotechnolgy Inc.

Nautilus Biotechnology Inc is a development stage life sciences company creating a platform technology for quantifying and unlocking the complexity of the human proteome. The Company transform the field of proteomics by democratizing access to the proteome and enabling fundamental advancements across human health and medicine. Its products includes: Proteome Analysis System, Reagent Kits, Software and analysis.

About MASS 908 Devices Inc.

908 Devices Inc develops a suite of purpose-built handheld devices for point-of-need chemical analysis. Leveraging mass spectrometry, optical spectroscopy, analytics and machine learning technologies, the company makes devices that are smaller and more accessible than conventional laboratory instruments. Its devices, including MX908, ThreatID, XplorIR and VipIR, are used to analyze unknown materials and provide actionable answers in health, safety and defense technology applications, addressing the fentanyl and illicit drug crisis, toxic carcinogen exposure and security threats. The company reimagines mass spectrometry technology by developing smaller, lower-cost and simpler-to-operate devices compared to conventional instruments, and generates maximum revenue from the United States.

Share on Social Networks: